Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8220249 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 7 Pages |
Abstract
In early-stage NSCLC managed with radiation alone, patients with SUVmax â¥7 on FDG-PET / CT scan have poorer outcomes and high risk of progression, possibly because of aggressive biology. There is a potential role for adjuvant therapies for these high-risk patients with intent to improve outcomes.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Vimoj J. MD, Robert MD, Abby MRT(T), Jason R. MD,